磁共振影像组学特征用于区分眼眶病变的良性与恶性
这项前瞻性单中心研究纳入200例术前接受3T MRI的眼眶病变患者,提取6个序列的影像组学特征构建随机森林模型,在测试集上鉴别良恶性的AUC为0.869,准确率0.840,敏感度0.684,特异度0.935,模型表现优于包括专家神经放射科医生在内的所有阅片者组(P<0.01)。
要点
- 基于3T MRI 6个序列提取的8个影像组学特征(含ADC均值、T1最大径及纹理特征)可辅助鉴别眼眶病变良恶性。
- 模型在测试集特异度0.935、敏感度0.684,敏感度相对偏低,阅片时需结合形态学避免漏诊恶性病变。
- 模型鉴别能力优于所有阅片者组包括专家神经放射科医生(P<0.01)。
核心结论
- MRI影像组学特征有助于区分眼眶病变的良性与恶性,且可能优于专家放射科医生。
研究设计与样本
- 经机构审查委员会批准的前瞻性单中心研究,2015年12月至2019年7月连续纳入术前行3T MRI的眼眶病变患者。
- 共纳入200例患者,女116例(58%)、男84例(42%),平均年龄53.0±17.9岁;良性病变126/200(63%),恶性病变74/200(37%)。
- 从T1加权成像、DIXON-T2加权成像、扩散加权成像、增强后DIXON-T1加权成像共6个MRI序列以Pyradiomics软件提取影像组学特征。
- 按观察者内与观察者间可重复性、非冗余性及序贯前向特征选择法筛选特征,在训练集(75%)以5折交叉验证训练并优化随机森林算法,在留出测试集(25%)以bootstrap 95%CI计算性能指标。
- 由5名住院医师、4名普通放射科医生和3名专家神经放射科医生在测试集上肉眼鉴别良恶性,读者组与模型间性能比较采用McNemar检验。
诊断标准与关键数值
- 共提取606个影像组学特征,训练集最佳模型由8个特征构成,包括表观扩散系数均值、T1加权成像最大径及纹理特征。
- 测试集受试者工作特征曲线下面积0.869(95%CI 0.834-0.898),准确率0.840(95%CI 0.806-0.874),敏感度0.684(95%CI 0.615-0.751),特异度0.935(95%CI 0.905-0.961)。
- 模型性能优于所有阅片者组包括专家神经放射科医生(P<0.01)。
- 加入临床与可分类影像数据未显著影响算法性能(P=0.49)。
临床应用与阅片要点
- 原文结论认为MRI影像组学特征有助于鉴别眼眶病变良恶性并可能优于专家放射科医生,未给出具体的日常阅片流程建议。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: Distinguishing benign from malignant orbital lesions remains challenging both clinically and with imaging, leading to risky biopsies. The objective was to differentiate benign from malignant orbital lesions using radiomics on 3 T magnetic resonance imaging (MRI) examinations.
MATERIALS AND METHODS: This institutional review board-approved prospective single-center study enrolled consecutive patients presenting with an orbital lesion undergoing a 3 T MRI prior to surgery from December 2015 to July 2019. Radiomics features were extracted from 6 MRI sequences (T1-weighted images [WIs], DIXON-T2-WI, diffusion-WI, postcontrast DIXON-T1-WI) using the Pyradiomics software. Features were selected based on their intraobserver and interobserver reproducibility, nonredundancy, and with a sequential step forward feature selection method. Selected features were used to train and optimize a Random Forest algorithm on the training set (75%) with 5-fold cross-validation. Performance metrics were computed on a held-out test set (25%) with bootstrap 95% confidence intervals (95% CIs). Five residents, 4 general radiologists, and 3 expert neuroradiologists were evaluated on their ability to visually distinguish benign from malignant lesions on the test set. Performance comparisons between reader groups and the model were performed using McNemar test. The impact of clinical and categorizable imaging data on algorithm performance was also assessed.
RESULTS: A total of 200 patients (116 [58%] women and 84 [42%] men; mean age, 53.0 ± 17.9 years) with 126 of 200 (63%) benign and 74 of 200 (37%) malignant orbital lesions were included in the study. A total of 606 radiomics features were extracted. The best performing model on the training set was composed of 8 features including apparent diffusion coefficient mean value, maximum diameter on T1-WIs, and texture features. Area under the receiver operating characteristic curve, accuracy, sensitivity, and specificity on the test set were respectively 0.869 (95% CI, 0.834-0.898), 0.840 (95% CI, 0.806-0.874), 0.684 (95% CI, 0.615-0.751), and 0.935 (95% CI, 0.905-0.961). The radiomics model outperformed all reader groups, including expert neuroradiologists (P < 0.01). Adding clinical and categorizable imaging data did not significantly impact the algorithm performance (P = 0.49).
CONCLUSIONS: An MRI radiomics signature is helpful in differentiating benign from malignant orbital lesions and may outperform expert radiologists.
引用
- Duron L, Heraud A, Charbonneau F, et al. A Magnetic Resonance Imaging Radiomics Signature to Distinguish Benign From Malignant Orbital Lesions. Invest Radiol. 2021. PMID: 32932375. doi:10.1097/RLI.0000000000000722
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。